Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early-stage Parkinson's Disease”

112 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 112 results

Testing effectiveness (Phase 2)UnknownNCT03242499
What this trial is testing

Lovastatin as a Neuroprotective Treatment for Early Stage Parkinson's Disease

Who this might be right for
Parkinson Disease
National Taiwan University Hospital 80
Testing effectiveness (Phase 2)Study completedNCT04928287
What this trial is testing

Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate)

Who this might be right for
Parkinson Disease
Hope Biosciences Research Foundation 24
Early research (Phase 1)Study completedNCT02728947
What this trial is testing

Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease

Who this might be right for
Parkinson's Disease
Luye Pharma Group Ltd. 28
Not applicableLooking for participantsNCT05286736
What this trial is testing

Neuroplasticity in Parkinson's Disease

Who this might be right for
ParkinsonParkinson Disease
University of Minnesota 50
Testing effectiveness (Phase 2)Looking for participantsNCT07166757
What this trial is testing

Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease

Who this might be right for
Parkinson Disease (PD)
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. 90
Testing effectiveness (Phase 2)Looking for participantsNCT06680830
What this trial is testing

Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Who this might be right for
Parkinson DiseaseParkinsonIdiopathic Parkinson Disease+2 more
Neuron23 Inc. 150
Large-scale testing (Phase 3)Study completedNCT00474058
What this trial is testing

Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine

Who this might be right for
Parkinson's Disease
UCB Pharma 287
Not applicableLooking for participantsNCT06916507
What this trial is testing

Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)

Who this might be right for
Parkinson's Disease
AbbVie 125
Not applicableWithdrawnNCT04536857
What this trial is testing

Detection of A-synuclein Aggregate as Biomarker in Diagnosing Parkinson's Disease at Early Stage by Using Protein Misfolding Cyclic Amplification (PMCA)

Who this might be right for
Parkinson's Disease
Huashan Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT06329141
What this trial is testing

Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

Who this might be right for
Parkinson Disease
Glaceum 90
Not applicableNot Yet RecruitingNCT06993142
What this trial is testing

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

Who this might be right for
Parkinson DiseaseProdromal StageNeurodegenerative Diseases+8 more
Radboud University Medical Center 600
Testing effectiveness (Phase 2)Study completedNCT04658186
What this trial is testing

A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease

Who this might be right for
Early-stage Parkinson's Disease
UCB Biopharma SRL 496
Not applicableLooking for participantsNCT07083089
What this trial is testing

Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR)

Who this might be right for
Mild Cognitive Impairment (MCI) AmnesticParkinson Disease (PD)Healthy Participants
Cilcare SAS 309
Large-scale testing (Phase 3)Study completedNCT02337751
What this trial is testing

A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants

Who this might be right for
Parkinson's Disease
Takeda 198
Testing effectiveness (Phase 2)UnknownNCT04220762
What this trial is testing

Determine the Dose of WIN-1001X by Evaluating Efficacy and Safety in Early Parkinson's Disease Patients

Who this might be right for
Parkinson Disease
Medi Help Line 188
Not applicableActive Not RecruitingNCT04261569
What this trial is testing

Clinical Trial for Near Infrared Endoventricular Illumination for Neuroprotection in Very Early Cases of Parkinson's Disease (Ev-NIRT)

Who this might be right for
Very Early Stage of Parkinson's Disease
University Hospital, Grenoble 14
Testing effectiveness (Phase 2)Ended earlyNCT02906020
What this trial is testing

A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of Venglustat (GZ/SAR402671) in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation

Who this might be right for
Parkinson's Disease
Genzyme, a Sanofi Company 273
Large-scale testing (Phase 3)Study completedNCT02337725
What this trial is testing

TVP-1012 (1 mg) in Early Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Takeda 244
Large-scale testing (Phase 3)Looking for participantsNCT06976268
What this trial is testing

Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

Who this might be right for
Parkinson Disease
Biohaven Therapeutics Ltd. 550
Large-scale testing (Phase 3)Study completedNCT03329508
What this trial is testing

Study With P2B001 in Subjects With Early Parkinson's

Who this might be right for
Parkinson DiseaseEarly Parkinson's Disease
Pharma Two B Ltd. 544
Load More Results